Back

Can we predict atrial fibrillation in Takotsubo syndrome?

13 May 2024 (15:51 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease 4 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Marta Bernardo

Hospital Center of Tras-os-Montes and Alto Douro, Vila Real (Portugal)

6 More presentations in this session

Presentation thumbnail
Late gadolinium enhancement regression in the follow-up of acute myocarditis episodes
Doctor A. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Comparisons in cardiovascular outcomes and mortality in patients diagnosed with hypertrophic cardiomyopathy
Doctor N. Reza (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
Associations between sex and cardiovascular outcomes in patients with hypertrophic cardiomyopathy
Doctor N. Reza (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
Direct abnormal communications between septal perforator arteries and cardiac chambers: a potential source of serious complications during alcohol septal ablation in hypertrophic cardiomyopathy
Doctor R. Sepp (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Comparison of clinical and echocardiographic characteristics before and after septal myectomy in patients with hypertrophic cardiomyopathy in a reference hospital in Colombia
Doctor L. Lopez Gutierrez (Medellin, CO)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in myocardial disease 4

The Event

Event poster

Heart Failure 2024

13 May 2024 15:51 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial strain and peak left ventricular outflow gradient are the main predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Left atrial strain as a predictor of atrial fibrillation in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Predicting atrial fibrillation in heart failure: added value of a plasma protein risk score over clinical and genomic models

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources